Authors:
RAFAEL E
DURAJ F
RUDSTROM H
WILCZEK H
ERICZON B
Citation: E. Rafael et al., EFFECT OF URSODEOXYCHOLIC ACID TREATMENT FOR CHOLESTASIS IN LIVER-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(6), 1995, pp. 3501-3502
Authors:
HAGGLUND H
RINGDEN O
LJUNGMAN P
WINIARSKI J
ERICZON B
TYDEN G
Citation: H. Hagglund et al., NO BENEFICIAL-EFFECTS, BUT SEVERE SIDE-EFFECTS CAUSED BY RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR FOR TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Transplantation proceedings, 27(6), 1995, pp. 3535-3535
Authors:
NEUHAUS P
PICHLMAYR R
WILLIAMS R
BECHSTEIN WO
BLUMHARDT G
MCMASTER P
MAYER D
BUCKELS J
CALNE R
FRIEND P
JOUGHIN C
WINKLER M
RINGE B
OTTO G
BLEYL J
DEVLIN J
OGRADY J
GROTH C
ERICZON B
DURAJ F
BISMUTH H
SAMUEL D
RUCAY P
Citation: P. Neuhaus et al., RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN PREVENTION OF LIVER ALLOGRAFT-REJECTION, Lancet, 344(8920), 1994, pp. 423-428